WW International (NASDAQ:WW – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($5.20) EPS for the quarter, missing the consensus estimate of ($2.45) by ($2.75), FiscalAI reports. The business had revenue of $168.26 million for the quarter, compared to analyst estimates of $158.53 million.
Here are the key takeaways from WW International’s conference call:
- Clinical (Med+) momentum — end-of-period clinical subscribers reached 197,000 (51% sequential growth) and clinical subscription revenue rose 32% year‑over‑year; clinical ARPU remains >4x behavioral and management expects clinical to be ~25–30% of 2026 revenue.
- Behavioral subscriber base continues to shrink — end-of-period behavioral subscribers were 2.5 million, down 25% year‑over‑year, contributing to Q1 revenue of $168 million, a 10% decline versus prior year.
- Company reaffirmed 2026 guidance (revenue $620–$635M; adjusted EBITDA $105–$115M), expects to generate cash in 2026, and will use $37 million in Q2 to reduce term‑loan principal, cutting ~$4 million of annual interest.
- Strategic positioning around GLP‑1s — management highlighted that combining FDA‑approved medications with WW behavioral support drives stronger outcomes (Med+ members in GLP‑1 Success lost 29.1% more body weight at 12 months) and sees orals/affordability expanding the addressable market.
- Margins and spending are mixed — Q1 adjusted gross margin stayed near a record at 73.6% despite a clinical mix shift, but marketing was front‑loaded at $93M and management expects modest gross‑margin pressure in 2026 while marketing as a percent of revenue increases slightly.
WW International Stock Up 11.2%
NASDAQ:WW traded up $1.03 during mid-day trading on Friday, hitting $10.20. 663,673 shares of the stock traded hands, compared to its average volume of 347,018. The business’s 50-day moving average price is $15.33 and its 200 day moving average price is $22.64. The company has a market cap of $101.99 million, a PE ratio of -1.76 and a beta of 1.30. WW International has a 12-month low of $8.36 and a 12-month high of $46.95.
Hedge Funds Weigh In On WW International
Wall Street Analysts Forecast Growth
Several brokerages have commented on WW. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of WW International in a research report on Friday, January 9th. Zacks Research raised shares of WW International from a “strong sell” rating to a “hold” rating in a research report on Monday, March 16th. Three analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce”.
Check Out Our Latest Stock Analysis on WW International
About WW International
WW International, Inc (NASDAQ: WW) is a global wellness and weight management company that provides a range of subscription-based programs, digital tools and personalized coaching services. Originally founded in 1963 by Jean Nidetch as a small support group in New York City, the company grew into the well-known Weight Watchers brand before rebranding as WW in 2018 to reflect an expanded focus on overall health, fitness and nutrition. Over the years, WW has introduced innovations such as the SmartPoints® system, which assigns values to foods based on their nutritional composition, and the MyWW® personalized wellness plan, which tailors recommendations to individual lifestyles and goals.
WW’s offerings span digital and in-person channels.
See Also
Receive News & Ratings for WW International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WW International and related companies with MarketBeat.com's FREE daily email newsletter.
